The November edition of Small Molecules of the Month includes two oral SARS-CoV-2 antivirals which may play an important role in life with endemic Covid, a remarkably selective CDK7 kinase inhibitor (>4000x), and a recently approved, once-daily MET inhibitor. If you find this series helpful, keep a close eye on drughunter.com in the coming days to catch what the team’s been working on for you behind the scenes…